Tagged with CRISPR

2023 FDA Drug Approvals: Second Highest Count in 30 Years
A Cystic Fibrosis Game Changer, Vertex Continues to Trailblaze
Embryonic Gene Editing: How Far is Too Far to Find a Treatment for Your Child?
Cell & Gene Therapy: CRISPR-Cas9 Nobel Prize Pioneers in Profile
The Cell & Gene Therapy Market: Coming into Its Own
China to Establish National Medical Ethics Committee Post-CRISPR Controversy
Jongmoon Kim – CEO, ToolGen, South Korea
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here